May 23, 2007 - MMH Offering Bladder Screening

By Stephanie Johnson
Marietta Memorial Hospital is offering a bladder cancer screening on June 7, 2007, from 5:00 7:00 pm in the Strecker Cancer Center.

Bladder cancer is the rapid growth of abnormal cells in the lining of the bladder. It is the fifth most common cancer in the United States.

The NMP22 BladderChek test is a painless and non-invasive urine test. This test has been approved by the FDA for the diagnosis of bladder cancer. It is a more definitive test and can detect DNA changes in the cells.

Risk factors include men and women age 50 and older, smokers, firefighters, occupational exposures to chemicals (aromatic amines) used in dry cleaning facilities and the production of dyes, paper, rope, apparel, rubber and petroleum.

The most common symptoms of bladder cancer include blood or blood clots in the urine (hematuria). Hematuria occurs in 80% to 90% of people who have bladder cancer and is the most common symptom. Usually it is not painful; pain during urination (dysuria); urinating small amounts frequently; frequent urinary tract infections (UTIs).

This screening is $10.00 and open to the public; please call 740-374-1634 to schedule your appointment.

Marietta Memorial is a not-for-profit community hospital, providing healthcare outreach education throughout Washington County and surrounding communities.

Posted: 2007-05-23
CONTACT: Jennifer Offenberger,
Director of Marketing & Public Relations
Marietta Memorial Hospital
Phone: 740-374-1797


Memorial Health System’s Accreditations & Awards
Memorial Health System
401 Matthew Street, Marietta, OH 45750
(740) 374-1400
© 2017, Memorial Health System.
Belpre Campus ER min
Marietta Memorial ER min
Selby ER min
Physicians Care Express-Marietta min
Physicians Care Express-Belpre min
Back to Top